393 related articles for article (PubMed ID: 19628284)
1. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
5. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
6. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.
Sun T; Gao Y; Tan W; Ma S; Zhang X; Wang Y; Zhang Q; Guo Y; Zhao D; Zeng C; Lin D
Clin Cancer Res; 2006 Dec; 12(23):7009-17. PubMed ID: 17145822
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF
Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency.
McAloon CJ; Wood AM; Gough SC; Stockley RA
Ther Adv Respir Dis; 2009 Feb; 3(1):23-30. PubMed ID: 19293200
[TBL] [Abstract][Full Text] [Related]
10. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression.
Borghese B; Chiche JD; Vernerey D; Chenot C; Mir O; Bijaoui G; Bonaiti-Pellié C; Chapron C
Hum Reprod; 2008 May; 23(5):1207-13. PubMed ID: 18308831
[TBL] [Abstract][Full Text] [Related]
12. The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China.
Shan K; Ying W; Jian-Hui Z; Wei G; Na W; Yan L
Mol Hum Reprod; 2005 Jun; 11(6):423-7. PubMed ID: 15879464
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L
Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
[TBL] [Abstract][Full Text] [Related]
14. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
16. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.
Bradbury PA; Zhai R; Hopkins J; Kulke MH; Heist RS; Singh S; Zhou W; Ma C; Xu W; Asomaning K; Ter-Minassian M; Wang Z; Su L; Christiani DC; Liu G
Carcinogenesis; 2009 May; 30(5):793-8. PubMed ID: 19321798
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
Kurzawski M; Modrzejewski A; Pawlik A; Droździk M
Clin Exp Dermatol; 2009 Jul; 34(5):613-7. PubMed ID: 19508478
[TBL] [Abstract][Full Text] [Related]
19. Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma.
Markiewicz L; Majsterek I; Przybylowska K; Dziki L; Waszczyk M; Gacek M; Kaminska A; Szaflik J; Szaflik JP
Acta Ophthalmol; 2013 Nov; 91(7):e516-23. PubMed ID: 23800300
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis.
Rech TF; Moraes SB; Bredemeier M; de Paoli J; Brenol JC; Xavier RM; Chies JA; Simon D
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
